Reneo Pharmaceuticals, Inc.
NASDAQ:RPHM
18.2 (USD) • At close October 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 35.97 | 20.375 | 27.632 | 11.737 | 9.081 | 30.395 | 19.927 | 62.132 | 118.264 | 121.094 | 124.66 | 126.409 | 140.368 | 91.221 | 53.613 | -24.887 |
Short Term Investments
| 40.704 | 62.46 | 75.331 | 113.877 | 133.596 | 63.392 | 81.246 | 53.948 | 8.588 | 17.568 | 23.01 | 31.325 | 26.963 | 0 | 0 | 49.774 |
Cash and Short Term Investments
| 76.674 | 82.835 | 102.963 | 125.614 | 142.677 | 93.787 | 101.173 | 116.08 | 126.852 | 138.662 | 147.67 | 157.734 | 167.331 | 91.221 | 53.613 | 24.887 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 1.316 | 1.092 | 3.659 | 3.158 | 3.643 | 3.231 | 5.18 | 9.836 | 10.318 | 8.106 | 12.128 | 9.862 | 7.62 | 4.678 | 1.412 | 0 |
Total Current Assets
| 77.99 | 83.927 | 106.622 | 128.772 | 146.32 | 97.018 | 106.353 | 120.998 | 132.011 | 142.715 | 153.734 | 162.665 | 171.141 | 93.56 | 55.025 | 24.887 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 0.574 | 0.648 | 0.733 | 1.535 | 1.64 | 1.769 | 1.745 | 1.427 | 1.519 | 1.619 | 0.212 | 0.2 | 0.085 | 0.081 | 0.069 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.153 | 0.064 | 0.081 | 0.081 | 0.079 | 0.081 | 0.084 | 0.079 | 0.078 | 0.078 | 0.078 | 0.078 | 0.078 | 1.68 | 0.127 | -24.887 |
Total Non-Current Assets
| 0.727 | 0.712 | 0.814 | 1.616 | 1.719 | 1.85 | 1.829 | 1.506 | 1.597 | 1.697 | 0.29 | 0.278 | 0.163 | 1.761 | 0.196 | -24.887 |
Total Assets
| 78.717 | 84.639 | 107.436 | 130.388 | 148.039 | 98.868 | 108.182 | 122.504 | 133.608 | 144.412 | 154.024 | 162.943 | 171.304 | 95.321 | 55.221 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 0.064 | 0.676 | 8.717 | 2.473 | 1.828 | 1.802 | 1.893 | 2.189 | 1.56 | 1.566 | 2.022 | 1.271 | 0.434 | 0.556 | 0.908 | 0 |
Short Term Debt
| 0.662 | 0.662 | 0.662 | 0.65 | 0.636 | 0.726 | 0.404 | 0.82 | 0.816 | 0.914 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.408 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.622 | 1.476 | 8.798 | 10.44 | 11.274 | 7.953 | 4.827 | 6.441 | 5.959 | 5.43 | 4.18 | 5.082 | 2.902 | 3.374 | 3.672 | 0 |
Total Current Liabilities
| 1.348 | 2.814 | 18.177 | 13.563 | 13.738 | 10.481 | 7.124 | 9.45 | 8.335 | 7.91 | 6.202 | 6.353 | 3.336 | 3.93 | 4.58 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 0.492 | 0.576 | 0.642 | 0.812 | 0.897 | 0.979 | 1.059 | 0.943 | 1.061 | 1.127 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.167 | 0.098 | 0.054 | 0.032 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -140.108 | 0 | 0 |
Other Non-Current Liabilities
| 0.008 | 0.007 | 0.007 | 1.069 | 0.876 | 0.324 | 0.029 | 0.066 | 0.055 | 0.057 | 0.611 | 0.382 | 0.417 | 140.108 | 92.756 | 0 |
Total Non-Current Liabilities
| 0.5 | 0.583 | 0.649 | 1.881 | 1.773 | 1.303 | 1.088 | 1.009 | 1.116 | 1.184 | 0.611 | 0.382 | 0.417 | 140.108 | 92.756 | 0 |
Total Liabilities
| 1.848 | 3.397 | 18.826 | 15.444 | 15.511 | 11.784 | 8.212 | 10.459 | 9.451 | 9.094 | 6.813 | 6.735 | 3.753 | 144.038 | 97.336 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 162.943 | 171.304 | 45.652 | 92.72 | 45.652 |
Common Stock
| 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0 | 0 | 0 |
Retained Earnings
| -232.261 | -226.9 | -218.474 | -190.517 | -171.321 | -151.79 | -136.683 | -123.083 | -110.076 | -97.764 | -84.728 | -74.121 | -61.386 | -52.17 | -44.958 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.013 | -0.012 | 0.008 | -0.021 | -0.031 | 0.012 | -0.043 | -0.026 | 0.168 | 0.064 | 0.034 | 0.017 | 0.005 | 0 | 0 | -23.127 |
Other Total Stockholders Equity
| 309.14 | 308.151 | 307.073 | 305.479 | 303.877 | 238.859 | 236.693 | 235.151 | 234.062 | 233.015 | 231.902 | 230.309 | 228.929 | 3.453 | -89.877 | 0 |
Total Shareholders Equity
| 76.869 | 81.242 | 88.61 | 114.944 | 132.528 | 87.084 | 99.97 | 112.045 | 124.157 | 135.318 | 147.211 | 156.208 | 167.551 | -48.717 | -42.115 | 22.525 |
Total Equity
| 76.869 | 81.242 | 88.61 | 114.944 | 132.528 | 87.084 | 99.97 | 112.045 | 124.157 | 135.318 | 147.211 | 156.208 | 167.551 | -48.717 | -42.115 | 22.525 |
Total Liabilities & Shareholders Equity
| 78.717 | 84.639 | 107.436 | 130.388 | 148.039 | 98.868 | 108.182 | 122.504 | 133.608 | 144.412 | 154.024 | 162.943 | 171.304 | 95.321 | 55.221 | 22.525 |